CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support in disease management. Its mission is to establish a global reference platform that aids clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By leveraging advanced technology, GenomeUp aims to accelerate diagnosis times, enhance patient care, and contribute to health prevention efforts, all within a 24-hour timeframe. Committed to social responsibility, the founders have transformed GenomeUp into an Italian Benefit Corporation, emphasizing sustainability, transparency, and a focus on the well-being of stakeholders, communities, and the environment.
Salute360
Seed Round in 2025
Salute360 is an online healthcare platform dedicated to providing reliable healthcare information and a variety of related services. The platform allows patients to book healthcare consultations and order medicines for home delivery within hours. Additionally, it facilitates connections between patients and local pharmacists and healthcare professionals, ensuring that healthcare services are easily available, affordable, and accessible.
Genoa Instruments
Venture Round in 2025
Genoa Instruments is a startup focused on advancing biomedical and health research through its innovative super-resolution optical microscopy technology. The company has developed a unique platform that integrates spatial and temporal super-resolution capabilities, allowing for detailed structural and functional imaging of living samples. Its offerings include a plug-and-play kit for image-scanning microscopy and next-generation confocal microscopy, enabling researchers to conduct quantitative studies using fluorescence optical microscopy. By making high-resolution imaging more accessible, Genoa Instruments aims to foster scientific discovery and enhance healthcare research.
EBAMed
Series A in 2025
EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.
Restorative Neurotechnologies
Series A in 2024
Restorative Neurotechnologies is focusing on the development of medical devices and innovative solutions for rehabilitation and cognitive enhancement.
Lymphatica Medtech
Series B in 2024
Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.
Genespire
Series B in 2024
Genespire is a biotechnology company dedicated to advancing gene therapies for individuals suffering from genetic disorders, with a specific emphasis on primary immunodeficiencies and inherited metabolic diseases. The company specializes in developing innovative therapies that utilize integration-defective lentiviral vectors combined with gene editing techniques. This approach allows for the precise and effective insertion of therapeutic genes into blood cells, providing patients with a range of tailored treatment options suitable for their unique conditions. Genespire's mission is to transform the lives of patients affected by severe genetic diseases through cutting-edge therapeutic solutions.
BionIT Labs
Venture Round in 2024
BionIT Labs focuses on integrating information technology with bionic solutions to enhance the lives of individuals with upper limb differences. The company has developed a myoelectric hand prosthesis that utilizes only two motors to control the movement of all fingers. This innovative design allows the prosthesis to automatically adapt to the shape and dimensions of various objects, facilitating improved functionality and dexterity for users. By addressing the challenges faced by individuals with disabilities, BionIT Labs aims to transform limitations into new possibilities, enabling users to navigate their daily lives more effectively.
Salute360
Pre Seed Round in 2022
Salute360 is an online healthcare platform dedicated to providing reliable healthcare information and a variety of related services. The platform allows patients to book healthcare consultations and order medicines for home delivery within hours. Additionally, it facilitates connections between patients and local pharmacists and healthcare professionals, ensuring that healthcare services are easily available, affordable, and accessible.
BionIT Labs
Seed Round in 2021
BionIT Labs focuses on integrating information technology with bionic solutions to enhance the lives of individuals with upper limb differences. The company has developed a myoelectric hand prosthesis that utilizes only two motors to control the movement of all fingers. This innovative design allows the prosthesis to automatically adapt to the shape and dimensions of various objects, facilitating improved functionality and dexterity for users. By addressing the challenges faced by individuals with disabilities, BionIT Labs aims to transform limitations into new possibilities, enabling users to navigate their daily lives more effectively.
Weart
Venture Round in 2021
Weart specializes in haptic technology aimed at digitalizing the sense of touch, enhancing experiences in virtual and augmented reality. The company develops wearable and portable devices that enable users to experience realistic tactile sensations, including texture, temperature, and forces. This technology allows for the recording and reproduction of tactile interactions, facilitating immersive VR training sessions in fields like medicine and industry, as well as improving in-store shopping and e-commerce by providing users with a more engaging experience. By merging concepts from science fiction with practical applications, Weart creates innovative solutions that enhance user interaction with digital environments.
Existo S.r.l.
Seed Round in 2021
Existo S.r.l. is a developer of innovative wearable technology aimed at enhancing human capabilities in daily living. The company's flagship product, Sixto, is a sixth robotic finger that serves as a wearable grasping device. Sixto features a single degree of freedom, allowing it to create a hybrid grasping mechanism that integrates with the user's hand. This technology not only augments the hand's grasping ability but also provides an intelligent holding point and can be personalized with interchangeable modules to suit various needs. Additionally, Sixto enables users to extend their grip away from the hand, making it particularly useful in potentially hazardous environments. The device is designed to assist individuals with disabilities by compensating for missing hand functions and improving overall functional scope.
BionIT Labs
Pre Seed Round in 2021
BionIT Labs focuses on integrating information technology with bionic solutions to enhance the lives of individuals with upper limb differences. The company has developed a myoelectric hand prosthesis that utilizes only two motors to control the movement of all fingers. This innovative design allows the prosthesis to automatically adapt to the shape and dimensions of various objects, facilitating improved functionality and dexterity for users. By addressing the challenges faced by individuals with disabilities, BionIT Labs aims to transform limitations into new possibilities, enabling users to navigate their daily lives more effectively.
InnovHeart
Series B in 2020
InnovHeart is a medical equipment manufacturing company that specializes in developing transcatheter mitral valve replacement systems. The company focuses on creating innovative implant technologies designed to treat patients with mitral valve disease. Its products aim to provide a safe, effective, and user-friendly solution for replacing incompetent mitral valves, allowing hospitals to address heart valve dysfunction more efficiently.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.